How modern biologics are transforming the pharma landscape – Financial Times

For several decades, small molecule drugs – produced mainly via chemical synthesis – have been the backbone of the pharmaceutical industry.

Read more here

Ready to collaborate or learn more about our services?

Find out how we can support your business.

Scroll to Top